Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹7.31 Cr₹10 Cr--₹0.83 Cr

What is the latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS is ₹7.31 Cr based on Mar2025 Standalone results.
Year Capital Work in Progress
Mar2025₹7.31 Cr
Mar2024₹10 Cr
Mar2023-
Mar2022-
Mar2021₹0.83 Cr

How is Capital Work in Progress of BAFNA PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹7.31 Cr
-30.33
Mar2024 ₹10 Cr
0
Mar2023 -
0
Mar2022 -
-100.00
Mar2021 ₹0.83 Cr -

Compare Capital Work in Progress of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹268.9 Cr -9.3% 3.3% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.3%

3.3%

49.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses